Eli Lilly Novo Nordisk Abnehmmedikamente Eli Lilly leaves Novo Nordisk in the dust in weight loss drug race
Eli Lilly Gewinn Abnehmmedikamente Eli Lilly sees 2026 profit above estimates as demand for weight‑loss drugs soars